With a market cap of has a large market cap size. AbbVie Inc. (NYSE: ABBV) has been on the stock market since its IPO date on the 1/2/2013. AbbVie Inc. is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for AbbVie Inc., is 9048.07, and so far today it has a volume of 3876440. Performance year to date since the 1/2/2013 is 15.06%.
To help you determine whether AbbVie Inc. is undervalued the following values will help you decide. P/E is 19.84 and forward P/E is 11.8. PEG perhaps more useful shows that AbbVie Inc. has a value for PEG of 1.24. P/S ratio is 4.4 and the P/B ratio is 23.07. The P/Cash and P/Free cash flow is *TBA and *TBA respectively.
At the current price AbbVie Inc. is trading at, 66.94 (1.08% today), AbbVie Inc. has a dividend yield of 3.44%, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is 3.34, and this is looking to grow in the next year to 18.10% after growing 185.20% this past year. EPS growth quarter over quarter is 32.50%, and 17.80% for sales growth quarter over quarter.
The number of shares outstanding is 1580.48, and the number of shares float is 1580.48. The senior management bring insider ownership to 0.10%, and institutional ownership is at 70.50%. The float short is 3.83%, with the short ratio at a value of 6.69. Management has seen a return on assets of *TBA, and also a return on investment of 16.90%.
The ability for AbbVie Inc., to deal with debt, means it current ratio is *TBA, and quick ratio is *TBA. Long term debt/equity is *TBA and total debt/equity is *TBA. In terms of margins, AbbVie Inc. has a gross margin of 79.80%, with its operating margin at 36.40%, and AbbVie Inc. has a profit margin of *TBA.
The 52 week high is -1.90%, with 51.59% being its 52 week low. The 20 day simple moving average is 8.14% and the 200 day simple moving average is 15.74%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.